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Abstract
In eukaryotes, pre-messenger RNA (pre-mRNA) splicing is an essential process in 
gene expression. Splicing is carried out by a dynamic multi-megadalton RNA-protein 
complex known as the spliceosome. Sequential transesterification reactions catalyzed 
by the spliceosome convert pre-mRNA to mRNA by removing the intervening 
sequences (introns) and joining the coding sequences (exons) together. Small nuclear 
RNAs (snRNAs) are essential splicing factors. Biallelic mutations of the human 
RNU4ATAC gene, which codes for U4atac snRNA, have been identified in patients 
diagnosed with Microcephalic Osteodysplastic Primordial Dwarfism type I (MOPD I). 
MOPD I is an autosomal recessive disorder characterized by extreme intrauterine 
growth retardation, multiple organ abnormalities, and typically early death. The 
mutations that have been studied biochemically reduce U4atac snRNA function and 
impair minor class (U12-dependent) intron splicing. Four novel patient mutations, 37 
G>A, 46 G>A, 48 G>A and 118 T>C, have recently been discovered. To evaluate the 
functional effects of these newly discovered mutations on U12-dependent splicing, we 
incorporated each of these mutations into a modified human RNU4ATAC gene 
construct by site directed mutagenesis. Following verification of the mutations by DNA 
sequencing, we prepared DNA for use in an in vivo splicing assay that is based on 
genetic suppression. These mutations are expected to affect the binding of proteins to 
U4atac snRNA that are important in formation of the catalytically active form of the 
spliceosome. We do not yet know how the consequent defective U12-dependent 
splicing affects gene expression and yields the MOPD I disease pathologies, but this 
study allows us to better understand the mechanistic basis of MOPD I and will serve 
as an important foundation for further studies and possible therapeutic intervention in 
the future.
